arrow
M

Motoki Sekikawa

Shizuoka Cancer Center
H指数:6
被引数:103

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study

多西他赛联合雷莫芦单抗对晚期非小细胞肺癌患者恶性胸腔积液和脑水肿的疗效:一项单机构回顾性研究

2026-05-010
OAAI
Weight change and impact on prognosis in patients with advanced non-small cell lung cancer with concomitant diabetes mellitus treated with sglt2 inhibitors

晚期非小细胞肺癌合并糖尿病且接受SGLT2抑制剂治疗患者的体重变化及其对预后的影响

2026-04-280
PRE
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations

奥希替尼对携带敏感EGFR突变且术后复发的非小细胞肺癌患者的疗效

2026-04-240
OAAI
Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study

多重用药对PD-1/PD-L1抑制剂治疗老年晚期非小细胞肺癌患者预后的影响: 一项回顾性队列研究

2024-09-010
PRE
Risk factors for severe immune-related adverse events after first-line pembrolizumab monotherapy or combination chemotherapy for non-small-cell lung cancer

非小细胞肺癌一线派姆单抗单药或联合化疗后严重免疫相关不良事件的危险因素

2022-10-136
PRE